NASDAQ: CGNT
$ 1.98 0.00 (0.00%)
Day High: N/A
Day Low:  N/A
Volume:    N/A
4:00 PM ET on Feb 17, 2017
Delayed ~20 min., by eSignal.
 
 
Press Releases
 
Press Releases
  Date Title View
Mar 30, 2015
MINNEAPOLIS and ORANGEBURG, N.Y., March 30, 2015 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) and Vision-Sciences, Inc. (NASDAQ: VSCI) shareholders have voted at the special meeting of each company's shareholders held today to approve the previously announced agreement and plan of merger between the two companies. "We are pleased with the outco...
Mar 3, 2015
MINNEAPOLIS, March 3, 2015 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, will host a meeting for shareholders and analysts on Thursday, March 12, 2015, beginning at 3:00 pm Central Time, at Uroplasty's corporate headquart...
Feb 27, 2015
MINNEAPOLIS, Feb. 27, 2015 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that it will participate in the 27th Annual ROTH Conference on Tuesday, March 10, 2015. Rob Kill, President and CEO, and Brett Reyno...
Feb 24, 2015
MINNEAPOLIS, Feb. 24, 2015 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that Cigna has written a positive coverage policy for Percutaneous Tibial Nerve Stimulation (PTNS) delivered via Uroplasty's Urgent...
Jan 22, 2015
MINNEAPOLIS, Jan. 22, 2015 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today reported financial results for the fiscal 2015 third quarter ended December 31, 2014. Global revenue for the Company's Urgent® PC Neuromod...
Jan 14, 2015
MINNEAPOLIS, Jan. 14, 2015 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, will release financial results for the fiscal third quarter ended December 31, 2014 after the market close on Thursday, January 22, 2015...
= add release to Briefcase

View archived press releases from Vision-Sciences and Uroplasty